.png)


Biospecimen Collection Programs
Scalable Biospecimen Collection Across a Real Clinical Network
Research Management Partners (RMP) provides end-to-end biospecimen collection services through an embedded clinical research network operating within active healthcare practices across the United States.
Our model enables sponsors, CROs, and biobanking organizations to access diverse patient populations and execute high-quality, protocol-compliant sample collection programs with speed, consistency, and full regulatory alignment.
What We Do
RMP supports the full lifecycle of biospecimen collection studies, including:
-
Patient identification and recruitment through EMR-integrated workflows
-
Informed consent and enrollment under IRB-approved protocols
-
Biospecimen collection performed by medically trained staff
-
On-site processing and preparation
-
IATA-compliant packaging and shipment
-
Real-time tracking and documentation
Our integrated approach ensures operational efficiency and high-quality sample integrity across all participating sites.
Types of Biospecimens Supported
We support a wide range of sample collection protocols, including:
-
Whole blood
-
Serum and plasma
-
Peripheral Blood Mononuclear Cells (PBMC)
-
DNA and RNA samples
-
Tissue samples (when applicable)
-
Stool and urine samples
All collections are performed in accordance with study-specific protocols and regulatory requirements.
Infrastructure & Operational Readiness
RMP provides a robust infrastructure designed to support biospecimen programs at scale:
-
Two dedicated laboratory environments for sample processing and handling
-
Temperature-controlled storage and handling procedures
-
IATA-trained personnel for compliant packaging and shipment
-
Standardized SOPs across all sites
-
Centralized regulatory and operational oversight
Our teams are trained in ICH-GCP and operate under strict quality and compliance frameworks.
The RMP Advantage
Unlike traditional biobanks or broker-based models, RMP operates directly within clinical care environments.
This enables:
-
Direct access to real, pre-qualified patient populations
-
Faster recruitment and enrollment timelines
-
Higher patient retention and protocol adherence
-
Consistent, high-quality sample collection
-
Real-time operational oversight across all sites
Our embedded SMO model ensures that biospecimen collection is not isolated from patient care—but fully integrated within it.
Who We Partner With
RMP collaborates with:
-
Biobanking organizations seeking U.S.-based collection partners
-
Contract Research Organizations (CROs) managing sample collection programs
-
Pharmaceutical and biotechnology sponsors requiring patient-driven biospecimen acquisition
We act as the execution partner, responsible for site-level operations, patient engagement, and sample collection.
Pilot Program Approach
For new collaborations, RMP supports pilot biospecimen programs across 2–3 sites to demonstrate:
-
Recruitment capability
-
Operational efficiency
-
Sample quality and compliance
This approach allows for rapid validation and scalable expansion across our network.
Get in Touch
If you are seeking a reliable U.S.-based partner for biospecimen collection programs, our team is ready to support your study.
Contact us to discuss active or upcoming opportunities.
​
“Request Biospecimen Collection Support”